載入...
The use of luspatercept for thalassemia in adults
Luspatercept is an activin receptor ligand trap that has been shown to enhance late-stage erythropoiesis in animal models of β-thalassemia. A multicenter, international, phase 2 dose-finding study was initiated in adult patients with β-thalassemia, either non–transfusion-dependent thalassemia (NTDT)...
Na minha lista:
| 發表在: | Blood Adv |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Society of Hematology
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7805339/ https://ncbi.nlm.nih.gov/pubmed/33570654 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020002725 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|